160 related articles for article (PubMed ID: 18374322)
1. Viral vector-mediated [corrected] expression of human collagen Q in cultured cells.
Ito M; Masuda A; Jinno S; Katagiri T; Krejci E; Ohno K
Chem Biol Interact; 2008 Sep; 175(1-3):346-8. PubMed ID: 18374322
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of acetylcholinesterase-associated collagen ColQ in fast- and slow-twitch muscle fibers.
Ting AK; Siow NL; Kong LW; Tsim KW
Chem Biol Interact; 2005 Dec; 157-158():63-70. PubMed ID: 16256971
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
[TBL] [Abstract][Full Text] [Related]
5. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG
Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737
[TBL] [Abstract][Full Text] [Related]
6. Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.
Ito M; Suzuki Y; Okada T; Fukudome T; Yoshimura T; Masuda A; Takeda S; Krejci E; Ohno K
Mol Ther; 2012 Jul; 20(7):1384-92. PubMed ID: 22371845
[TBL] [Abstract][Full Text] [Related]
7. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction.
Cartaud A; Strochlic L; Guerra M; Blanchard B; Lambergeon M; Krejci E; Cartaud J; Legay C
J Cell Biol; 2004 May; 165(4):505-15. PubMed ID: 15159418
[TBL] [Abstract][Full Text] [Related]
8. Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinations.
Ito M; Ohno K
Matrix Biol; 2018 Aug; 68-69():628-636. PubMed ID: 29475025
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterases regulation in the absence of ColQ.
Sigoillot SM; Bourgeois F; Legay C
Chem Biol Interact; 2010 Sep; 187(1-3):84-9. PubMed ID: 20153305
[TBL] [Abstract][Full Text] [Related]
10. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
Ohno K; Ito M; Masuda A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal neural regulation of extrajunctional acetylcholinesterase and collagen Q in rat muscles--the role of calcineurin signaling.
Trinkaus M; Pregelj P; Sketelj J
Chem Biol Interact; 2008 Sep; 175(1-3):45-9. PubMed ID: 18582853
[TBL] [Abstract][Full Text] [Related]
12. Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene.
Müller JS; Petrova S; Kiefer R; Stucka R; König C; Baumeister SK; Huebner A; Lochmüller H; Abicht A
Neuropediatrics; 2004 Jun; 35(3):183-9. PubMed ID: 15248101
[TBL] [Abstract][Full Text] [Related]
13. Myocyte enhancer factor 2 mediates acetylcholine-induced expression of acetylcholinesterase-associated collagen ColQ in cultured myotubes.
Lau FT; Choi RC; Xie HQ; Leung KW; Chen VP; Zhu JT; Bi CW; Chu GK; Tsim KW
Mol Cell Neurosci; 2008 Nov; 39(3):429-38. PubMed ID: 18718538
[TBL] [Abstract][Full Text] [Related]
14. COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.
Arredondo J; Lara M; Ng F; Gochez DA; Lee DC; Logia SP; Nguyen J; Maselli RA
Hum Genet; 2014 May; 133(5):599-616. PubMed ID: 24281389
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional organization of synaptic acetylcholinesterase.
Aldunate R; Casar JC; Brandan E; Inestrosa NC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):96-104. PubMed ID: 15572165
[TBL] [Abstract][Full Text] [Related]
16. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
[TBL] [Abstract][Full Text] [Related]
17. [Construction of recombinant adeno-associated virus vector co-expressing hVEGF165 and hBMP-7 genes].
Huang X; Shi Z; Wang K; Dang X; Yang P; Yu P
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):807-13. PubMed ID: 18681280
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
[TBL] [Abstract][Full Text] [Related]
19. Developmental consequences of the ColQ/MuSK interactions.
Karmouch J; Dobbertin A; Sigoillot S; Legay C
Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase and molecular interactions at the neuromuscular junction.
Guerra M; Cartaud A; Cartaud J; Legay C
Chem Biol Interact; 2005 Dec; 157-158():57-61. PubMed ID: 16289501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]